Evidence map›Paper›PMID 42627462›Full record

ArticleMolecular imaging and biology2026

Exploration of Chemokine Receptor 4 Targeted [

Yanlin Liu, Hongyuan Dai, Chenyu Sun, Yuewen Sun, Tian Tian, Rui Huang

Abstract read
PubMed Publisher
In one paragraph

Article in Molecular imaging and biology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Yanlin LiuDepartment of Nuclear Medicine, West China Hospital of Sichuan University, No.37 Guoxue Alley, Chengdu, 610041, China.ORCID http://orcid.org/0009-0005-8141-3601
Hongyuan DaiDepartment of Nuclear Medicine, West China Hospital of Sichuan University, No.37 Guoxue Alley, Chengdu, 610041, China.
Chenyu SunDepartment of Nuclear Medicine, West China Hospital of Sichuan University, No.37 Guoxue Alley, Chengdu, 610041, China.
Yuewen SunDepartment of Nuclear Medicine, West China Hospital of Sichuan University, No.37 Guoxue Alley, Chengdu, 610041, China.
Tian TianDepartment of Nuclear Medicine, West China Hospital of Sichuan University, No.37 Guoxue Alley, Chengdu, 610041, China.
Rui HuangDepartment of Nuclear Medicine, West China Hospital of Sichuan University, No.37 Guoxue Alley, Chengdu, 610041, China. huang_rui@scu.edu.cn.ORCID http://orcid.org/0000-0003-3191-0528

Funding

National Natural Science Foundation of China NSFC82403761Science and Technology Department of Sichuan Province 2024YFFK0025
6 · The paper itself

Abstract

purposeThis study compared the diagnostic performance of [

methodsParticipants with RAIR-DTC were prospectively enrolled and underwent both [

resultsNineteen patients with RAIR-DTC (median age, 60 years) were analyzed. A total of 125 lesions were identified, with 92.8% detected on [

conclusion[

Indexed as

[18F]FDG[68Ga]Ga-PentixaforChemokine receptor 4Radioiodine-refractory differentiated thyroid cancer

Identifiers

PMID42627462

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.